| |
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
| 1 |
[GO] |
2026―Jan―23 |
State of intestinal biocenosis and features of the coprogram in children with inflammatory bowel diseases who have suffered COVID-19 |
O. A. Savvateeva, D. V. Pechkurov, A. A. Tyazheva, A. V. Gorelov |
| 2 |
[GO] |
2025―Sep―01 |
Clinical features of COVID-19 in hospitalized patients with non-alcoholic fatty liver disease |
S. A. Alieva, I. G. Nikitin, I. V. Vasilyeva |
| 3 |
[GO] |
2025―Jul―15 |
A complex case of liver echinococcosis after coronavirus infection |
S. N. Styazhkina, D. V. Zaitsev, A. A. Tselousov, R. K. Ayubov |
| 4 |
[GO] |
2025―Jul―15 |
COVID-19 in children with chronic digestive system pathology |
M. S. Rajkovic, S. B. Chuelov, S. K. Pylaeva, D. D. Saveleva, A. A. Chernysheva, A. L. Rossina, et al. (+5) M. A. Sayfullin, A. N. Slatetskaya, E. G. Tsimbalova, E. E. Petryaykina, O. V. Shamsheva |
| 5 |
[GO] |
2025―Feb―03 |
Catestatin and proinflammatory cytokines as biomarkers of metabolic syndrome in combination with arterial hypertension and obstructive sleep APNEA syndrome in COVID-19 patients |
S. A. Tokarev, I. V. Gubareva, L. Yu. Shvan, S. G. Kochetkov, G. I. Kiseleva, O. E. Gaberman, et al. (+3) Yu. Yu. Vukolova, A. V. Pashentseva, N. V. Savelyeva |
| 6 |
[GO] |
2025―Feb―03 |
Sarcopenia and COVID-19 - a complex pathological duet |
S. V. Bulgakova, D. P. Kurmaev, E. V. Treneva |
| 7 |
[GO] |
2024―Okt―22 |
Features of the course of the new coronavirus infection COVID-19 in chronic kidney disease |
A. S. Abyzov, V. A. Kichigin, L. V. Tarasova |
| 8 |
[GO] |
2024―Jun―19 |
The efficacy of the Maxiflor Maximum synbiotic for the correction of gastrointestinal dysfunction in patients after COVID-19 |
T. M. Bogdanova, T. Yu. Kalyuta, V. A. Semenova, A. S. Fedonnikov, A. P. Bykova |
| 9 |
[GO] |
2024―Jun―19 |
Chemomicrobiome study of preobiotic and antibiotic properties of bioflavonoids and polyphenols, promising for the treatment of COVID-19 and other viral infections |
O. A. Gromova, I. Yu. Torshin, A. G. Chuchalin |
| 10 |
[GO] |
2024―Jun―19 |
Interaction of SARS-CoV-2 with gut microbiota |
O. V. Soldatova, I. Ya. Goryanskaya, L. E. Namazova, K. I. Abramova |
| 11 |
[GO] |
2024―Mrz―26 |
COVID-19 liver damage. Features of laboratory and instrumental diagnostics |
S. V. Tarasenko, D. A. Glotov, O. D. Peskov, S. N. Sokolova, U. V. Zhuchkova, T. S. Rakhmaev, et al. (+5) I. V. Bakonina, A. Yu. Bogomolov, D. O. Tyulenev, S. N. Brovkina, S. G. Bykova |
| 12 |
[GO] |
2024―Mrz―26 |
The effect of the new coronavirus infection on the human pancreas |
S. V. Tarasenko, D. A. Glotov, O. D. Peskov, S. N. Sokolova, U. V. Zhuchkova, T. S. Rakhmaev, et al. (+6) I. V. Bakonina, A. Yu. Bogomolov, D. O. Tyulenev, S. N. Brovkina, S. G. Bykova, S. V. Gurov |
| 13 |
[GO] |
2024―Mrz―08 |
Some clinical and pathogenetic aspects of irritable bowel syndrome in patients who have undergone COVID-19 |
A. V. Nalyotov, T. I. Shapchenko, N. P. Guz |
| 14 |
[GO] |
2024―Mrz―08 |
The debut of autoimmune hepatitis after a new coronavirus infection (COVID-19) in an 11-month-old child |
T. N. Lebedeva, A. Yu. Marchukova, K. G. Bondar |
| 15 |
[GO] |
2024―Mrz―07 |
Endoscopic diagnostics and treatment of esophagitis in patients after COVID-19 |
N. E. Chernekhovskaya, I. Yu. Korzheva, A. V. Volova, A. V. Povalyaev, V. G. Andreev |
| 16 |
[GO] |
2023―Okt―10 |
The debut of autoimmune hepatitis after a new coronavirus infection (COVID-19) in an 11-month-old child |
T. N. Lebedeva, A. U. Marchukova, K. G. Bondar |
| 17 |
[GO] |
2023―Jul―26 |
Features of the course of liver cirrhosis in the background of infection with COVID-19 |
A. B. Krivosheev, L. A. Khvan, Anna Yu. Reimer, O. N. Gerasimenko, V. P. Drobisheva, A. Yu. Reimer |
| 18 |
[GO] |
2023―Jan―26 |
Microbiota of the small intestine in patients with COVID-19 |
Yu. S. Karpeeva, K. A. Klikunova, A. G. Platonova, E. V. Balukova |
| 19 |
[GO] |
2023―Jan―26 |
The conjugacy of the use of synbiotic Maxilac® with the severity and duration of the course of COVID-19 in outpatient treatment |
O. V. Soldatova, I. Ya. Goryanskaya, E. A. Zaharyan, V. S. Ivanchenko |
| 20 |
[GO] |
2023―Jan―26 |
Crohn’s disease and COVID-19: points of contact |
A. A. Markova, E. I. Kashkina, A. V. Aparkina, L. V. Artyuhina, V. I. Krasnikova |
| 21 |
[GO] |
2023―Jan―19 |
The gastrointestinal tract is the gate of entrance for COVID-19 |
N. M. Khomeriki |
| 22 |
[GO] |
2023―Jan―19 |
Gastroenterological disorders in patients with COVID-19 |
V. I. Sharobaro, V. V. Malik, V. A. Kornalevskaya |
| 23 |
[GO] |
2023―Jan―19 |
Analysis of outpatient attendances of gastroenterological patients against the backdrop of COVID-19 pandemic |
S. V. Shelukhina, A. S. Vasilevskaya, M. A. Butov, I. A. Zagravskaya, O. A. Maslova, E. V. Markova |
| 24 |
[GO] |
2022―Nov―21 |
Association of genetic prerequisites of vitamin D deficiency with severity of past COVID-19 infection |
E. V. Shrayner, S. K. Petukhova, A. I. Khavkin, N. V. Kokh, G. I. Lifshits |
| 25 |
[GO] |
2022―Okt―07 |
Abnormal liver function tests in patients with COVID-19 |
Diana I. Abdulganieva, Dilyara D. Mukhametova, Nailya G. Shamsutdinova, Alsou M. Galieva |
| 26 |
[GO] |
2022―Okt―07 |
Cytolytic syndrome in patients with COVID-19 |
Alisa M. Lukmanova, Albina R. Isanbaeva, Gulnar M. Sakhautdinova |
| 27 |
[GO] |
2022―Okt―07 |
The frequency of ulcerative-erosive defects and ulcerative bleeding of the gastroduodenal zone in patients with coronavirus infection COVID-19 |
N. N. Butorin, V. V. Tsukanov, R. V. Asyayev, M. N. Butorina, A. V. Vasyutin, J. L. Tonkikh |
| 28 |
[GO] |
2022―Okt―07 |
Features of respiratory tests (hydrogen + methane), indirect liver elastometry data in COVID-19 convalescents (pilot study) |
Margarita V. Kruchinina, Irina O. Svetlova, Irina I. Logvinenko, Andrey A. Gromov, Elena V. Kashtanova, Natalia E. Ponomareva, Elina V. Kruchinina |
| 29 |
[GO] |
2022―Okt―07 |
Clinical and pathogenic features of COVID-19- associated diarrhea syndrome |
G. S. Dzhulay, T. E. Dzhulay |
| 30 |
[GO] |
2022―Okt―06 |
Features of diagnosis and course of acute appendicitis during the COVID-19 pandemic |
S. N. Styazhkina, N. A. Kiryanov, A. A. Abramovich, A. A. Valinurov, D. V. Zaitsev, A. I. Andrianov, et al. (+3) I. M. Gallyamov, A. A. Nikitin, I. M. Saitgalin |
| 31 |
[GO] |
2022―Okt―06 |
Clinical case of a new coronavirus infection in a patient with severe Crohn’s disease |
V. N. Larina, E. V. Kudina, E. N. Sheregova, P. N. Bespalova, N. F. Revina |
| 32 |
[GO] |
2022―Okt―06 |
Gastroenterological manifestations of SARS-CoV-2 and possible consequences of the infection |
L. A. Fomina, K. E. Nemirov, E. M. Sacharova |
| 33 |
[GO] |
2022―Okt―05 |
Metabolic support of antiviral therapy in patients with COVID-19 |
A. A. Shuldyakov, E. P. Lyapina, A. N. Smagina, O. B. Lisko |
| 34 |
[GO] |
2022―Okt―05 |
Wilson-Konovalov disease in a patient after COVID-19 infection |
A. V. Aparkina, E. I. Kashkina, A. A. Markova, K. D. Dorogoikina, R. V. Lyakisheva |
| 35 |
[GO] |
2022―Okt―05 |
Extrapulmonary manifestations of SARS-CoV-2: a new coronavirus infectionas an aggravating factor in peptic ulcer disease |
B. N. Levitan, V. V. Skvortsov, N. V. Eremenko |
| 36 |
[GO] |
2021―Dez―23 |
Hyperenzymemia after vaccination against COVID-19: complex equation with simple variables |
L. Yu. Ilchenko, I. G. Fedorov, G. G. Totolyan, A. M. Karelina, G. A. Sedova, G. E. Finkelberg, et al. (+2) E. Yu. Termosesova, I. G. Nikitin |
| 37 |
[GO] |
2021―Nov―19 |
Mallory- Weiss syndrome associated with new coronavirus infection COVID-19 |
T. V. Goma, N. M. Kozlova, Yu. N. Bykov |
| 38 |
[GO] |
2021―Sep―01 |
Gastrointestinal tract diseases at different stages of COVID-19 in children |
G. S. Karpovich, I. V. Kuimova, A. E. SHestakov, I. Ya. Izvekova, L. M. Panasenko, A. P. Pomogaeva, et al. (+2) L. V. Lukashova, A. N. Evstropov |
| 39 |
[GO] |
2021―Sep―01 |
Acute gastroenteritis with a new coronavirus infection in Novosibirsk residents |
E. I. Krasnova, V. V. Provorova, N. I. Khokhlova, E. V. Borodina, O. B. Sheronova, N. V. Tikunova, et al. (+7) V. G. Kuznetsova, I. V. Kuimova, I. Ya. Izvekova, L. M. Panasenko, A. P. Pomogaeva, L. V. Lukashova, A. N. Evstropov |
| 40 |
[GO] |
2021―Jul―21 |
Microbiome, probiotics, and COVID-19: promising approaches to support innate and acquired immunity systems |
O. A. Gromova, I. Yu. Torshin, A. G. Chuchalin, V. A. Maksimov |
| 41 |
[GO] |
2021―Mai―22 |
Management of patients with digestive diseases during the COVID-19 pandemic. Clinical Practice Guidelines by the Russian scientific medical society of internal medicine (RSMSIM) and the Gastroenterological Scientific Society of Russia (2nd edition) |
V. B. Grinevich, Yu. A. Kravchuk, V. I. Ped, E. I. Sas, S. P. Salikova, I. V. Gubonina, et al. (+14) E. I. Tkachenko, S. I. Sitkin, L. B. Lazebnik, E. V. Golovanova, E. A. Belousova, P. A. Makarchuk, E. Yu. Eremina, A. S. Sarsenbaeva, D. I. Abdulganieva, L. V. Tarasova, O. A. Gromova, V. A. Ratnikov, K. V. Kozlov, A. K. Ratnikova |
| 42 |
[GO] |
2021―Mai―22 |
Liver damage while Covid-19: problems of pathogenesis and treatment |
E. A. Lyalyukova, I. V. Dolgalev, E. N. Chernysheva, I. V. Druk, G. M. Konovalova, A. V. Lyalyukov |
| 43 |
[GO] |
2021―Apr―07 |
Functional gastrointestinal diseases and the COVID-19 pandemic: the view of an outpatient gastroenterologist |
M. A. Butov, A. S. Vasilevskaya, S. V. Shelukhina, I. A. Zagravskaya, O. A. Maslova, V. B. Ardatova, et al. (+2) S. A. Vorob’Eva, R. . Shebbi |
| 44 |
[GO] |
2021―Apr―07 |
Clinic and semiotics of digestive lesions with coronavirus SARS-CoV-2 |
N. G. Kucherenko, A. K. Ratnikova, V. B. Grinevich, E. I. Tkachenko, Yu. A. Kravchuk |
| 45 |
[GO] |
2021―Mrz―17 |
Digestional diseases in Covid-19 in children |
L. A. Kharitonova, I. M. Osmanov, A. A. Ploskireva, O. N. Solodovnikova, Yu. E. Milova |
| 46 |
[GO] |
2020―Dez―24 |
Features of intestinal damage in COVID-19 |
A. S. Sarsenbaeva, L. B. Lazebnik |
| 47 |
[GO] |
2020―Sep―28 |
Virus-bacterial association of SARS-CoV-2 with mycoplasma as one of the possible causes of severe forms of COVID-19 |
L. N. Chikhireva, A. M. Cherkashov, E. D. Li, O. A. Chikhirev, Yu. N. Belenkov |
| 48 |
[GO] |
2020―Sep―28 |
Management of patients with digestive diseases during the COVID-19 pandemic: Clinical Practice Guidelines by the Gastroenterological Scientific Society of Russia |
V. B. Grinevich, Yu. A. Kravchuk, V. I. Ped, E. I. Sas, S. P. Salikova, I. V. Gubonina, et al. (+4) E. I. Tkachenko, S. I. Sitkin, L. B. Lazebnik, E. V. Golovanova |
| 49 |
[GO] |
2020―Aug―04 |
The effectiveness and safety of a polypeptide drug (Laennec) for the treatment of COVID-19 |
V. A. Maksimov, I. Yu. Torshin, A. G. Chuchalin, O. N. Tkacheva, I. D. Strazhesko, O. A. Gromova |
| 50 |
[GO] |
2020―Aug―04 |
Diarrhea when COVID-19 in adults |
A. S. Sarsenbaevа, L. B. Lazebnik |
| 51 |
[GO] |
2020―Aug―04 |
Original SARS-CoV-2 vaccine model |
I. E. Khoroshilov |
| 52 |
[GO] |
2020―Jun―25 |
Pathology of the digestive tract and liver with COVID-19 |
E. P. Yakovenko, A. V. Yakovenko, A. N. Ivanov, N. A. Agafonova |
| 53 |
[GO] |
2020―Jun―25 |
Features of management of patients with gastroenterological pathology in the conditions of the COVID-19 pandemic |
V. B. Grinevich, Yu. A. Kravchuk, E. I. Tkachenko, A. M. Pershko, V. I. Ped, I. E. Sas, et al. (+3) I. V. Gubonina, L. B. Lazebnik, O. V. Stefanyuk |
| 54 |
[GO] |
2020―Mai―05 |
The defeat of the digestive system during infection SARS-CoV-2 |
Oksana V Stefanyuk, Leonid B Lazebnik |
